Skip to main content
. 2022 Mar 30;26(1):78–87. doi: 10.5114/wo.2022.115678

Fig. 1.

Fig. 1

Flow cytometric histogram analysis in breast cancer patients and control, all samples were labeled with antibodies against CD45 PE and CK19FITC. CK19 expression in control (A), CK19 expression in stage II (B), CK19 expression in stage III (C), CK19 expression in stage IV (D)